Previous studies have reported that the amount of IL-2 produced by T cells from patients and mice with SLE is reduced, which is thought to contribute to increased susceptibility to infection, reduced activation-induced cell death, and subsequent prolonged survival of autoreactive lymphocytes (3). Here, IL2 is linked to systemic lupus erythematosus.